Lv1
50 积分 2024-07-22 加入
Development of Lipid-Engineered PSMA-Targeted Radioligands with Quinoline Scaffold
12天前
已完结
Acridine-Based [68Ga]Ga- and [18F]AlF-Labeled PSMA Radiotracers Enabling High-Contrast PET Imaging with Minimized Undesired Retention
12天前
已完结
Preclinical Evaluation of [68Ga]Ga-CS03 as a Novel GPC3-Targeted Probe for Imaging GPC3 in Hepatocellular Carcinoma Models
19天前
已完结
68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer
27天前
已完结
Development and Evaluation of an Albumin-Binding GPC3-Targeting Peptide for PET Imaging of Hepatocellular Carcinoma
30天前
已完结
Development and Advantages of O-(Carboxymethyl)-L-tyrosine-Based PSMA-Targeting Theranostics for Prostate Cancer
1个月前
已完结
Structure-Guided Designed [18F]-labeled FAPI for Enhanced Hydrophilicity: From Preclinical to First-In-Human Study
1个月前
已完结
Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers
1个月前
已完结
Preclinical and exploratory human studies of novel 68Ga-labeled D-peptide antagonist for PET imaging of TIGIT expression in cancers
1个月前
已完结
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
2个月前
已完结
皖公网安备34019202002308
